NCT07814560Not yet recruiting
Metabolic Syndrome and Risk of Chronic Philadelphia Negative Myeloproliferative Neoplasms
Source: ClinicalTrials.gov · Last updated 11 Sept 2026
Brief summary (registry, in English)
Studying the role of metabolic syndrome in chronic Myeloproliferative neoplasms (MPNs)
- Status (registry)
- Not yet recruiting
- Study type
- Observational
- Enrollment
- 313 (estimated)
- First submitted
- 6 Sept 2026
- Start date
- 1 Dec 2026
- Primary completion date
- 1 Dec 2027
- Lead sponsor
- Assiut University
- NCT number
- NCT07814560
What you commit to
- Study type: Observational
- Planned participants: 313
- From 1 Dec 2026 to the primary completion date, 1 Dec 2027
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- remission
Who the study is looking for
- chronic Philadelphia negative Myeloproliferative Neoplasms
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.